Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis. [PDF]
Abdlkadir AS +7 more
europepmc +1 more source
Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]
Zhang J, Mensel B, Baum RP.
europepmc +1 more source
Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients. [PDF]
Mohindroo C, Ramirez RA.
europepmc +1 more source
My Life as a "Theranostician": A commentary on the evolution of theranostics. [PDF]
Hicks RJ.
europepmc +1 more source
Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision Oncology. [PDF]
Coppa J +12 more
europepmc +1 more source
Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study. [PDF]
Santo G +9 more
europepmc +1 more source
Radiopharmaceutical Theranostics in Primary Adrenal Malignancies: A Surgeon's Perspective. [PDF]
Laskou S +9 more
europepmc +1 more source
Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors - A single center study of 378 patients. [PDF]
Slott C +10 more
europepmc +1 more source
Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints. [PDF]
Neculai-Candea LS +8 more
europepmc +1 more source
Radioligand Therapy in Meningiomas: Today's Evidence, Tomorrow's Possibilities. [PDF]
Sipka G +12 more
europepmc +1 more source

